CLINICA BAVIERA SACLINICA BAVIERA SACLINICA BAVIERA SA

CLINICA BAVIERA SA

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪476.06 M‬EUR
‪35.97 M‬EUR
‪224.92 M‬EUR
‪1.65 M‬
Beta (1Y)
−0.22

About CLINICA BAVIERA S.A.

CEO
Eduardo Baviera Sabater
Headquarters
Madrid
Employees (FY)
‪1.47 K‬
Founded
1992
ISIN
ES0119037010
FIGI
BBG000R3L5M4
Clínica Baviera SA is engaged in the provision of diagnosis and treatment for eye disorders. It specializes in the treatment of glaucoma, cataract, vitreous and retinal detachment, and strabismus or squinting. The company was founded by Eduardo Baviera Sabater, Julio Baviera Sabater, Luis Miguel Raga, and Fernando Llovet Osuna on February 5, 1992 and is headquartered in Madrid, Spain.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of D9Z is 29.40 EUR — it hasn't changed in the past 24 hours. Watch CLINICA BAVIERA SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CLINICA BAVIERA SA stocks are traded under the ticker D9Z.
D9Z stock has risen by 1.38% compared to the previous week, the month change is a 4.26% rise, over the last year CLINICA BAVIERA SA has showed a 36.11% increase.
We've gathered analysts' opinions on CLINICA BAVIERA SA future price: according to them, D9Z price has a max estimate of 26.30 EUR and a min estimate of 26.30 EUR. Watch D9Z chart and read a more detailed CLINICA BAVIERA SA stock forecast: see what analysts think of CLINICA BAVIERA SA and suggest that you do with its stocks.
D9Z reached its all-time high on Apr 5, 2024 with the price of 29.20 EUR, and its all-time low was 21.60 EUR and was reached on Dec 4, 2023. View more price dynamics on D9Z chart.
See other stocks reaching their highest and lowest prices.
D9Z stock is 0% volatile and has beta coefficient of −0.22. Track CLINICA BAVIERA SA stock price on the chart and check out the list of the most volatile stocks — is CLINICA BAVIERA SA there?
Today CLINICA BAVIERA SA has the market capitalization of ‪476.03 M‬, it has increased by 0.34% over the last week.
Yes, you can track CLINICA BAVIERA SA financials in yearly and quarterly reports right on TradingView.
CLINICA BAVIERA SA is going to release the next earnings report on Jul 23, 2024. Keep track of upcoming events with our Earnings Calendar.
As of Jun 2, 2024, the company has ‪1.47 K‬ employees. See our rating of the largest employees — is CLINICA BAVIERA SA on this list?
Like other stocks, D9Z shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLINICA BAVIERA SA stock right from TradingView charts — choose your broker and connect to your account.